SCHEMBL1824288

SCHEMBL1824288

COC(=O)CC(N)C(Cc1ccccc1)c1ccc(OS(C)(=O)=O)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G1B P04054 1/20 0.43
ATG4B Q9Y4P1 1/20 0.43
LTA4H P09960 1/20 0.41
KCNA5 P22460 1/20 0.40
MAOB P27338 1/20 0.40
MMP1 P03956 3/20 0.39
MMP2 P08253 1/20 0.39
MMP3 P08254 1/20 0.39
PDE4A P27815 1/20 0.39
PDE4B Q07343 1/20 0.39
PDE4C Q08493 1/20 0.39
PDE4D Q08499 1/20 0.39
PPARG P37231 2/20 0.39
MMP9 P14780 1/20 0.38
MMP13 P45452 1/20 0.38
STS P08842 1/20 0.38
PPARA Q07869 2/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
ACHE P22303 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1824709 0.91 LTA4H (0.43) PLA2G1BATG4BLTA4HKCNA5MAOB
SCHEMBL1827457 0.89 PPARG (0.44) PLA2G1BATG4BLTA4HPPARGSTS
SCHEMBL1823667 0.89 PLA2G1B (0.42) PLA2G1BATG4BLTA4HKCNA5MAOB
SCHEMBL1823785 0.89 TSHR (0.42) PLA2G1BATG4BLTA4HPPARGSTS
SCHEMBL1826292 0.89 PPARG (0.47) PLA2G1BATG4BLTA4HPPARGPPARA
SCHEMBL1827399 0.88 ABCB1 (0.41) PLA2G1BATG4BPPARGSTSPPARA
SCHEMBL1822808 0.87 PLA2G1B (0.39) PLA2G1BATG4BKCNA5MAOBMMP1
SCHEMBL27343057 0.85 KCNA5 (0.49) PLA2G1BATG4BLTA4HKCNA5MMP1
SCHEMBL1822379 0.85 P2RX7 (0.46) PPARGMEN1KMT2AALDH1A1
SCHEMBL1824254 0.81 CA1 (0.45) PLA2G1BATG4BLTA4HKCNA5PDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2161254-B1 Intermediate for preparing a biaryl compound SUMITOMO CHEMICAL CO (JP) 2014-08-13 EP disclosed
EP-1481967-B1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS SUMITOMO CHEMICAL CO (JP) 2011-05-04 EP disclosed
US-7714157-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-05-11 US disclosed
EP-2161254-A1 Intermediate for preparing a biaryl compound Sumitomo Chemical Company, Limited (JP) 2010-03-10 EP disclosed
US-20070270603-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2007-11-22 US disclosed
US-7271280-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-09-18 US disclosed
EP-1481967-A1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS Sumitomo Chemical Company, Limited (JP) 2004-12-01 EP disclosed
US-20040158093-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040158093-A1 Process for preparing a biaryl compound CYP1B1, REL, CYP2F1 PLA2G1B 4470/4885ATG4B 3296/4885LTA4H 3852/4885
US-20070270603-A1 Process for preparing a biaryl compound CYP4A11, CYP4B1, CYP51A1 PLA2G1B 4673/4885ATG4B 734/4885LTA4H 3332/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.